JPRN-UMIN000003458
Completed
未知
effect of antihypertensive combination therapy with either CCB or diuretics on irbesartan on hypertensive patient with metabolic syndrome:A randomised controlled trial - effect of antihypertensive combination therapy
Kanazawa Medical University Diabetes & Endocrinology0 sites40 target enrollmentApril 7, 2010
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- hypertensive patient with metabolic syndorome
- Sponsor
- Kanazawa Medical University Diabetes & Endocrinology
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Hypersensitivity 2\)Pregnant woman or possibility of pregnancy 3\)Diuretic and CCB are administered 4\)Steroid or the immunosuppressive agent is taken 5\)Patient who judged that doctor in charge is improper
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Antihypertensive effect of combination therapy of telmisartan and low dose hydrochrolthiazide in hypertemnsive patientsJPRN-UMIN000000798on profit Organization LINE60
Completed
Phase 4
Comparing anti-hypertensive combination therapy of fixed dose losartan and hydrochlorothiazide(HCTZ) versus angiotensin receptor blocker(ARB) and calcium channel blocker(CCB) on hypertensive patients whose blood pressures don't lower enough,effect and influence of metabolic system trial.HypertensionJPRN-UMIN000001692Hypertension and Metabolism Study group in East Saitama300
Completed
Not Applicable
The effects of combined therapy for hypertension on arterial functiohypertension, type 2 diabetes mellitusJPRN-jRCT1091220034Masumi Ai, MD, PhDBioethics Research Center, Tokyo Medical and Dental University60
Completed
Phase 4
Combination of Antihypertensive therapy in the elderly, Multicenter Investigation <CAMUI> Multi-center randomized controlled study on efficacy of ARB/Diuretic mixture versus ARB/Ca channel blocker combination therapy to blood pressure or cognitive function in the elderly patients who have insufficient controlled hypertension in ARB monotherapyHypertensionJPRN-UMIN000001688Elderly Hypertension Conference200
Completed
Not Applicable
Evaluation for drug combination of antihypertensive agent and lipid-lowering agent in patients with hypertension and dyslipidemiaHypertension and dyslipidemiaJPRN-UMIN000008539Saitama Medical Center, Saitama Medical University30